Current evidence for the hepatoprotective activities of the medicinal mushroom Antrodia cinnamomea
Open Access
- 1 January 2013
- journal article
- Published by Springer Nature in Chinese Medicine
- Vol. 8 (1) , 21
Abstract
Antrodia cinnamomea (AC) is an endemic mushroom species of Taiwan, and has been demonstrated to possess diverse biological and pharmacological activities, such as anti-hypertension, anti-hyperlipidemia, anti-inflammation, anti-oxidation, anti-tumor, and immunomodulation. This review focuses on the inhibitory effects of AC on hepatitis, hepatocarcinoma, and alcohol-induced liver diseases (e.g., fatty liver, fibrosis). The relevant biochemical and molecular mechanisms are addressed. Overall, this review summarizes the hepatoprotective activities in vitro and in vivo. However, there is no doubt that human and clinical trials are still limited, and further studies are required for the development of AC-related products.Keywords
This publication has 86 references indexed in Scilit:
- Personal habits and indoor combustions. Volume 100 E. A review of human carcinogens.2012
- Methyl Antcinate A from Antrodia camphorata Induces Apoptosis in Human Liver Cancer Cells through Oxidant-Mediated Cofilin- and Bax-Triggered Mitochondrial PathwayChemical Research in Toxicology, 2010
- Inhibitory effects of antrodins A–E from Antrodia cinnamomea and their metabolites on hepatitis C virus proteasePhytotherapy Research, 2008
- Angiogenesis and anti-angiogenesis in hepatocellular carcinomaCancer Treatment Reviews, 2006
- The Anti-Angiogenic Effect of SinomenineAngiogenesis, 2005
- ABC of diseases of liver, pancreas, and biliary system: Acute hepatitisBMJ, 2001
- Viruses, Immunity, and Cancer: Lessons from Hepatitis BThe American Journal of Pathology, 2000
- The Role of the Vascular Phase in Solid Tumor Growth: A Historical ReviewNeoplasia, 1999
- Geographic Variation of p53 Mutational Profile in Nonmalignant Human LiverScience, 1994
- Pathology of Alcoholic Liver DiseasesSeminars in Liver Disease, 1981